275 related articles for article (PubMed ID: 20302683)
1. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
LaForce CF; Carr W; Tilles SA; Chipps BE; Storms W; Meltzer EO; Edwards M
Allergy Asthma Proc; 2010; 31(2):132-40. PubMed ID: 20302683
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
LaForce CF; Carr W; Tilles SA; Chipps BE; Storms W; Meltzer EO; Edwards M
Allergy Rhinol (Providence); 2010 Apr; 1(2):14. PubMed ID: 28569236
[TBL] [Abstract][Full Text] [Related]
3. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
[TBL] [Abstract][Full Text] [Related]
5. Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis.
Lieberman P; Meltzer EO; LaForce CF; Darter AL; Tort MJ
Allergy Asthma Proc; 2011; 32(2):151-8. PubMed ID: 21352639
[TBL] [Abstract][Full Text] [Related]
6. Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis.
Kaliner MA; Storms W; Tilles S; Spector S; Tan R; LaForce C; Lanier BQ; Chipps B
Allergy Asthma Proc; 2009; 30(3):255-62. PubMed ID: 19549426
[TBL] [Abstract][Full Text] [Related]
7. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis.
Berger WE; Ratner PH; Casale TB; Meltzer EO; Wall GM
Allergy Asthma Proc; 2009; 30(6):612-23. PubMed ID: 20031007
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
Ilyina NI; Edin AS; Astafieva NG; Lopatin AS; Sidorenko IV; Ukhanova OP; Khanova FM
Int Arch Allergy Immunol; 2019; 178(3):255-263. PubMed ID: 30677766
[TBL] [Abstract][Full Text] [Related]
12. Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate.
Patel D; Garadi R; Brubaker M; Conroy JP; Kaji Y; Crenshaw K; Whitling A; Wall GM
Allergy Asthma Proc; 2007; 28(5):592-9. PubMed ID: 18034980
[TBL] [Abstract][Full Text] [Related]
13. Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms.
Baroody FM; Logothetis H; Vishwanath S; Bashir M; Detineo M; Naclerio RM
Am J Rhinol Allergy; 2013 Jan; 27(1):48-53. PubMed ID: 23406601
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of sensory attributes of two antihistamine nasal sprays: olopatadine 0.6% and azelastine 0.1%.
Meltzer EO; Garadi R; Laforce C; Chadwick SJ; Berger WE; Gross G; Edwards MR; Crenshaw K; Wall GM
Allergy Asthma Proc; 2008; 29(6):659-68. PubMed ID: 19144261
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study.
Yamamoto H; Yamada T; Kubo S; Osawa Y; Kimura Y; Oh M; Susuki D; Takabayashi T; Okamoto M; Fujieda S
Allergy Asthma Proc; 2010; 31(4):296-303. PubMed ID: 20819319
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis.
Meltzer EO; Hampel FC; Ratner PH; Bernstein DI; Larsen LV; Berger WE; Finn AF; Marple BF; Roland PS; Wall GM; Brubaker MJ; Dimas C; Potts SL; Silver LH; Barnes JR
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):600-6. PubMed ID: 16400902
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar.
Ratner PH; Hampel FC; Amar NJ; van Bavel JH; Mohar D; Marple BF; Roland PS; Wall GM; Brubaker MJ; Drake M; Turner D; Silver LH
Ann Allergy Asthma Immunol; 2005 Nov; 95(5):474-9. PubMed ID: 16312171
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitis.
Fairchild CJ; Meltzer EO; Roland PS; Wells D; Drake M; Wall GM
Allergy Asthma Proc; 2007; 28(6):716-23. PubMed ID: 18201438
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive report of olopatadine 0.6% nasal spray as treatment for children with seasonal allergic rhinitis.
Meltzer EO; Blaiss M; Fairchild CJ
Allergy Asthma Proc; 2011; 32(3):213-20. PubMed ID: 21477426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]